Literature DB >> 26254365

Pro-apoptotic and Growth-inhibitory Effect of IFN-β-Overexpressing Canine Adipose Tissue-derived Mesenchymal Stem Cells Against Melanoma Cells.

Sei-Myoung Han1, Chong-Woo Park1, Jin-Ok Ahn1, Sang-Chul Park1, Woo-Sung Jung1, Kyoung-Won Seo2, Jeong-Chan Ra3, Sung-Keun Kang3, Hee-Woo Lee4, Hwa-Young Youn4.   

Abstract

BACKGROUND: Canine melanoma is the most common type of tumor in dogs. We investigated the effects of canine interferon-beta (cIFN-β)-overexpressing adipose tissue-derived mesenchymal stem cells (cATMSCs) on apoptosis and proliferation of canine melanoma cells.
MATERIALS AND METHODS: Expression of IFN-β in cATMSCs was confirmed using reverse transcription-polymerase chain reaction and enzyme linked immunosorbent assays. Flow cytometry was performed for cell-cycle analysis and apoptotic cell quantification of LMeC (melanoma) cells. Protein expression of cyclin D1, procaspase-3, activated caspase-3, and Bcl-2 homologous antagonist killer (Bak) was evaluated by western blot analysis.
RESULTS: Decreased proportions of cells in S- and G0/G1 phases were observed in parallel with decreased cyclin D1 expression in LMeC cells treated with cIFN-β-cATMSC-conditioned media. Protein expression of active forms of caspase 3 and Bak increased in response to treatment with cIFN-β-cATMSC-conditioned media.
CONCLUSION: IFN-β overexpression by cATMSCs was associated with pro-apoptotic and growth-inhibitory effects on canine melanoma cells. The antitumor effects of these cells have therapeutic potential for the treatment of canine melanoma. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Melanoma; apoptosis; cell cycle; interferon β; mesenchymal stem cells

Mesh:

Substances:

Year:  2015        PMID: 26254365

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Mesenchymal stem cells maintain the stemness of colon cancer stem cells via interleukin-8/mitogen-activated protein kinase signaling pathway.

Authors:  Xiaoying Ma; Jiajun Liu; Xiaotong Yang; Kai Fang; Peiyong Zheng; Xin Liang; Jianwen Liu
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-02

2.  Long-Term Management with Adipose Tissue-Derived Mesenchymal Stem Cells and Conventional Treatment in a Dog with Hepatocutaneous Syndrome.

Authors:  A Nam; S-M Han; D-M Go; D-Y Kim; K-W Seo; H-Y Youn
Journal:  J Vet Intern Med       Date:  2017-08-07       Impact factor: 3.333

Review 3.  Translational Animal Models Provide Insight Into Mesenchymal Stromal Cell (MSC) Secretome Therapy.

Authors:  Rebecca M Harman; Charlotte Marx; Gerlinde R Van de Walle
Journal:  Front Cell Dev Biol       Date:  2021-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.